Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Disease Associations
Enalapril plus lercanidipine had better blood pressure response rate than enalapril and HCTZ
March 6th, 2006
Enalapril plus lercanidipine had a slightly better blood pressure response rate than enalapril plus hydrochlorothiazide. According to a study from Germany, "Angiotensin-converting enzyme inhibitors plus dihydropyridine calcium channel blockers or low-dose thiazide diuretics are considered first-line therapies in hypertensive diabetic patients as glucose metabolism is not relevantly affected. Most diabetic patients require at least two different drug classes to achieve the recommended target blood pressure of 130/85 mmHg." R. Agrawal and colleagues at the Hannover Medical School explained, "This controlled clinical trial investigated the calcium...
Source: Obesity & Diabetes Week (2006-03-06)
|
